Nalaganje...
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory...
Shranjeno v:
| izdano v: | J Cardiovasc Transl Res |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer US
2020
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7892683/ https://ncbi.nlm.nih.gov/pubmed/32222950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-020-09994-3 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|